Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study.
Saved in:
| Title: | Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study. |
|---|---|
| Authors: | Douma, Li-Anne H1 (AUTHOR), Lalezari, Ferry2 (AUTHOR), van der Noort, Vincent3 (AUTHOR), de Vries, Jeltje F3 (AUTHOR), Monkhorst, Kim4 (AUTHOR), Smesseim, Illaa1 (AUTHOR), Baas, Paul1 (AUTHOR), Schilder, Bodien1 (AUTHOR), Vermeulen, Marrit3 (AUTHOR), Burgers, Jacobus A1 (AUTHOR) s.burgers@nki.nl, de Gooijer, Cornedine J1 (AUTHOR) |
| Source: | Lancet Oncology. Nov2023, Vol. 24 Issue 11, p1219-1228. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173319033 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Douma%2C+Li-Anne+H%22">Douma, Li-Anne H</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lalezari%2C+Ferry%22">Lalezari, Ferry</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+der+Noort%2C+Vincent%22">van der Noort, Vincent</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Vries%2C+Jeltje+F%22">de Vries, Jeltje F</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Monkhorst%2C+Kim%22">Monkhorst, Kim</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Smesseim%2C+Illaa%22">Smesseim, Illaa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baas%2C+Paul%22">Baas, Paul</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schilder%2C+Bodien%22">Schilder, Bodien</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vermeulen%2C+Marrit%22">Vermeulen, Marrit</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burgers%2C+Jacobus+A%22">Burgers, Jacobus A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> s.burgers@nki.nl</i><br /><searchLink fieldCode="AR" term="%22de+Gooijer%2C+Cornedine+J%22">de Gooijer, Cornedine J</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet+Oncology%22">Lancet Oncology</searchLink>. Nov2023, Vol. 24 Issue 11, p1219-1228. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173319033 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(23)00446-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1219 Titles: – TitleFull: Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Douma, Li-Anne H – PersonEntity: Name: NameFull: Lalezari, Ferry – PersonEntity: Name: NameFull: van der Noort, Vincent – PersonEntity: Name: NameFull: de Vries, Jeltje F – PersonEntity: Name: NameFull: Monkhorst, Kim – PersonEntity: Name: NameFull: Smesseim, Illaa – PersonEntity: Name: NameFull: Baas, Paul – PersonEntity: Name: NameFull: Schilder, Bodien – PersonEntity: Name: NameFull: Vermeulen, Marrit – PersonEntity: Name: NameFull: Burgers, Jacobus A – PersonEntity: Name: NameFull: de Gooijer, Cornedine J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: Nov2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 14702045 Numbering: – Type: volume Value: 24 – Type: issue Value: 11 Titles: – TitleFull: Lancet Oncology Type: main |
| ResultId | 1 |